Skip to main content

Divisions

Technologies

About us

Insights

See all Insights

News

Updates and announcements

19 January 2026
Helyx Industries is born: a rebranding that consolidates a new three-division industrial structure

Press releases

26 December 2025
Comunicazione eventi societari 2026

Press releases

19 December 2025
Comunicazione di variazione del capitale sociale, deposito attestazione ai sensi dell'art. 2444 C.C. e statuto aggiornato

Press releases

12 December 2025
Efficacia del cambio di denominazione sociale da "Ulisse Biomed S.p.A." a "Helyx Industries S.p.A."
    Contact us
    18 November, 2022

    Updates and announcements

    Hyris and Singlabs signed a distributorship agreement for Singapore

    Hyris and Signlabs will partner together to commercialize Hyris signature technology, Hyris System™, and Hyris testing solutions in Singapore.

    Related links:

    Singlabs

    19 January 2026

    Helyx Industries is born: a rebranding that consolidates a new three-division industrial structure

    CONTINUE TO READING
    07 August 2025

    Papillomavirus Screening: Self-sampling with HPV-Selfy is Effective and Well-Accepted by Women, a New Study Confirms.

    CONTINUE TO READING
    06 August 2025

    COMMUNICATION OF CONCESSION FOR POR FESR 2021-2027

    CONTINUE TO READING
    09 May 2025

    Ulisse Biomed supports the fight against malaria

    CONTINUE TO READING
    14 April 2025

    The innovative soul of Ulisse Biomed: the research and development that drives our future

    CONTINUE TO READING
    12 March 2025

    Hyris expands testing rapid technology aimed at supporting the fight against malaria

    CONTINUE TO READING
    29 January 2025

    New partnership agreement with Capebio

    CONTINUE TO READING
    20 January 2025

    NEW DISTRIBUTION AGREEMENT WITH MONTEBELLO DIAGNOSTICS

    CONTINUE TO READING
    18 December 2024

    A new brand identity for the Group

    CONTINUE TO READING
    09 December 2024

    Microbiota: a market with high potential

    CONTINUE TO READING